Lung involvement is common in Hodgkin's disease, occurring in 15-40% of patients (Ellman and Bowdler, 1960) . Its radiology has been described in detail by Sheinmel et al. (1950) and Wolpaw et al. (1944) and its pathology by Stolberg et al. (1964) . However, these reports and others, such as that of Peckham (1972) , have been descriptive rather than analytical. In this paper all the patients attending a large regional centre over a 16-year period were studied and 122 cases of pulmonary involvement were analysed.
Patients and methods
The case notes of all patients with Hodgkin's disease in the Nottingham area from 1960 to 1975 inclusive were assessed. Only patients with unequivocal histological proof of the disease were included, and the standard classification by Lukes et al. (1966) was used. All the chest radiographs taken during or after 1969 were reviewed by the author. The criteria for accepting lung involvement in Hodgkin's disease were: (1) presence of a lesion proven by necropsy, lung biopsy or bronchial biopsy to be Hodgkin's disease involving the lung (92 patients); (2) presence of a nontransient radiographic lung lesion responsive only to Hodgkin's disease chemotherapy or to radiotherapy in a patient with Hodgkin's disease (21 patients); or (3) radiographic appearances typical of pulmonary involvement in a patient with Hodgkin's disease (9 patients). Radiographic and postmortem evidence of hilar or mediastinal node involvement and of other intrathoracic complications was noted. Pulmonary involvement was subdivided radiographically in a simplified version of the classification of Sheinmel et al. (1950) . Table 2 . All types of change occurred slightly more frequently in the right lung than in the left, especially 'pneumonic' infiltration (15R, 4L) and direct invasion (17R, 7L). About one-third of changes noted were bilateral, although nodules were bilateral in seven out of 12 cases. Table 3 shows the histological classification in the 276 patients in whom this was known. Three of the eight patients without histological classification had lung involvement. The group with pulmonary involvement contained significantly fewer with lymphocyte predominance (P<001). There was no significant correlation between histology and radiographic type of lung involvement. Lung involvement was proven in 92 cases (75%)-by necropsy in 83 patients, by bronchial biopsy in eight patients, and by lung biopsy in one patient. Dyspnoea was the only significant symptom, being reported by 26 patients.
Results
Radiotherapy was given to the involved lung in 13 patients but produced a partial response in only two. However, 29 of the 71 patients given chemotherapy showed complete resolution of the radiographic lesions, with partial response in 34 patients and no response in eight patients. Thus chemotherapy was markedly superior to radiotherapy.
The interval between diagnosis of Hodgkin's disease and the first evidence of pulmonary involvement ranged up to 11 years, with a mean of Mediastinal node enlargement was strongly associated with both hilar node enlargement (47 of 66 cases) and pulmonary involvement (47 of 66 cases). Mediastinal nodes showed similar response rates to radiotherapy and chemotherapy, and again no histological type predominated.
OTHER INTRATHORACIC INVOLVEMENT
Of the 284 patients, 32 (11%) developed pleural effusions which persisted or disappeared only on specific treatment. Twenty-three of these patients also had pulmonary involvement. The effusion was unilateral in all but three of the patients. Pleural plaques were seen in 24 patients-20 of these had pulmonary involvement. Rib erosions were seen in nine patients, leading to pathological fracture in two patients. Sternal erosions developed in two patients and two patients had pericardial effusions.
Discussion
Before the advent of chemotherapy pulmonary involvement was regarded as a late complication of Hodgkin's disease, giving a poor prognosis (Levinson et al., 1957) . The survival rates without chemotherapy in the present study confirm this finding. However, lung involvement responds well to chemotherapy, with a massive rise in two-and five-year survival rates. A considerable proportion of the patients in this study had received chemotherapy before the modern chemotherapy regimens were standardised. Thus current survival figures are likely to be even better than those presented. Of patients given modern chemotherapy, those with lung involvement appear to fare as well as those without. However, small numbers prevent detailed analysis of this point.
The present study shows that lung involvement is a common feature in Hodgkin's disease-perhaps commoner than is often realised. It occurred more frequently than hilar node involvement, and over three-quarters of patients with hilar node enlargement also developed lung involvement. In one-third of all patients studied, lung involvement provided the first evidence of stage IV disease. Thus the role of the routine chest radiograph in monitoring the progress of Hodgkin's disease is well founded. Most previous studies have noted a strong association between hilar and lung disease but that lung involvement without mediastinal disease does occur occasionally (Sheinmel et al., 1950; Ellman and Bowdler, 1960; Kern et al., 1961) . However, a recent study by Whitcomb et al. (1972) noted hilar lymphadenopathy in all 29 patients with lung involvement and felt that, without hilar nodes, lung involvement is distinctly unlikely. In the present series 31 patients had lung manifestations without hilar or mediastinal node enlargement, and 23 of these cases were supported by postmortem findings. Thus hilar node enlargement is by no means a prerequisite for lung involvement. This can be important practically, in the differential diagnosis of a lung lesion in a patient with Hodgkin's disease. Some authors such as Verse (1931) and Kern et al. (1961) have noted cases of Hodgkin's disease confined solely to the lungs, but none was found in this study and this presentation is likely to be very rare.
While the radiological appearances of pulmonary Hodgkin's disease are well described, the frequency of occurrence of the various radiological types is less well documented. The present results fit in well with the theory of Wolpaw et al. (1944) that the distribution of involvement is primarily governed by the location of the lymphoid tissue within the lung. The major site of organised lymphoid tissue is at points of bifurcation of bronchi and pulmonary vessels (Stolberg et al., 1964; Murray, 1976) , and infiltration occurs along peribronchial and perivascular lymphatics.
In the present study this is indeed much the most common type of involvement seen radiographically. Direct spread along peribronchial lymphatics from hilar nodes is another variant whose predicted frequency seems to be confirmed in practice. At the onset of pulmonary involvement over two-thirds of patients already had stage IIIB or stage IV disease. In two-thirds of these patients the diagnosis had been made at least two months before pulmonary involvement occurred. Thus nowadays almost half the patients would have started chemotherapy before their lung involvement had a chance to occur. Since chemotherapy treats this complication effectively, the incidence of lung involvement is likely to fall with modem chemotherapy regimens. 
